CIK 0001125345 · Non-accelerated filer<br>Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,086
- in 1 filing, $129K under 10b5-1 plans
Net −$129,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Koenig Scott President and CEO | Option exercise · Restricted Stock Unit | −42,341 | 84,659 | ||
| 2024-02-15 | Cilinski Lynn VP, Controller and Treasurer | Option exercise | +6,668 | 8,591 | ||
| 2024-02-15 | Cilinski Lynn VP, Controller and Treasurer | Shares withheld for taxes | −2,378 | $17.40 | $41K | 6,213 |
| 2024-02-15 | Cilinski Lynn VP, Controller and Treasurer | Option exercise · Restricted Stock Unit | −6,668 | 13,332 | ||
| 2024-02-15 | Risser Eric Blasius Chief Operating Officer | Option exercise | +16,670 | 70,938 | ||
| 2024-02-15 | Risser Eric Blasius Chief Operating Officer | Shares withheld for taxes | −5,879 | $17.40 | $102K | 65,059 |
| 2024-02-15 | Risser Eric Blasius Chief Operating Officer | Option exercise · Restricted Stock Unit | −16,670 | 33,330 | ||
| 2024-02-15 | Karrels James SVP, CFO and Secretary | Option exercise | +15,003 | 206,779 | ||
| 2024-02-15 | Karrels James SVP, CFO and Secretary | Shares withheld for taxes | −5,327 | $17.40 | $93K | 201,452 |
| 2024-02-15 | Karrels James SVP, CFO and Secretary | Option exercise · Restricted Stock Unit | −15,003 | 29,997 | ||
| 2024-02-15 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise | +13,336 | 13,336 | ||
| 2024-02-15 | Spitznagel Thomas Sr VP, Technical Ops | Shares withheld for taxes | −5,020 | $17.40 | $87K | 8,316 |
| 2024-02-15 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise · Restricted Stock Unit | −13,336 | 26,664 | ||
| 2024-02-15 | Bonvini Ezio Sr VP, Research & CSO | Option exercise | +16,670 | 88,004 | ||
| 2024-02-15 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −5,871 | $17.40 | $102K | 82,133 |
| 2024-02-15 | Bonvini Ezio Sr VP, Research & CSO | Option exercise · Restricted Stock Unit | −16,670 | 33,330 | ||
| 2024-02-08 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee Stock Option (right to buy) | +45,000 | $18.30 | $824K | 45,000 |
| 2024-02-08 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Restricted Stock Unit | +17,000 | 17,000 | ||
| 2024-02-08 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Employee Stock Option (right to buy) | +71,000 | 71,000 | ||
| 2024-02-08 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Restricted Stock Unit | +27,000 | 27,000 |
Page 16 of 17 · 322 trades